Fehlings, M., Jhunjhunwala, S., Kowanetz, M., O’Gorman, W. E., Hegde, P. S., Sumatoh, H., . . . Yadav, M. (2019). Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment. J Immunother Cancer.
Citação norma ChicagoFehlings, Michael, et al. "Late-differentiated Effector Neoantigen-specific CD8+ T Cells Are Enriched in Peripheral Blood of Non-small Cell Lung Carcinoma Patients Responding to Atezolizumab Treatment." J Immunother Cancer 2019.
Citação norma MLAFehlings, Michael, et al. "Late-differentiated Effector Neoantigen-specific CD8+ T Cells Are Enriched in Peripheral Blood of Non-small Cell Lung Carcinoma Patients Responding to Atezolizumab Treatment." J Immunother Cancer 2019.